The review is devoted to pharmacometabonomics - a new branch of science focused on personalization of drug therapy through the comprehensive analysis of metabolites of patient's biological fluids. It considers the history of pharmacometabonomic, positioning to other “-omic” sciences, and system approach, realized by this science, in determination of individual therapeutic dose of the drugs and also a technical implementation of pharmacometabonomic based on direct mass spectrometry of blood plasma metabolites. Special attention is paid to a comparative analysis of pharmacometabonomics and other main approaches to personalized therapy in the clinic, such as pharmacogenetics and therapeutic drug monitoring. Finally, prospects of pharmacometabonomics applications in clinical practice were also discussed.
Keywords: pharmacometabonomics, metabolomics, metabonomics, pharmacogenomics, mass spectrometry, personalized medicine, therapeutic drug monitoring
Wami W.M., Buntinx F., Bartholomeeusen S., Goderis G., Mathieu C., Aerts M. (2013) British Journal of General Practice: the journal of the Royal College of General Practitioners, 63(609), 267-273. Scholar google search
Dettmer K., Hammock B.D. (2004) Environmental Health Perspectives, 112(7), A396-A397. Scholar google search
Harrigan G.G., Goodacre R. (2003) Metabolic Profiling: Its Role in Biomarker Discovery and Gene Function Analysis (Harrigan G.G., Goodacre R., eds.). Boston, MA: Springer US. CrossRef Scholar google search
Mini E., Nobili S. (2009) Clinical cases in mineral and bone metabolism: the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases, 6(1), 17-24. Scholar google search